You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 163 No. 15, August 11, 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Lipids and Lipid Disorders
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic

Regression of Carotid and Femoral Artery Intima-Media Thickness in Familial Hypercholesterolemia

Treatment With Simvastatin

Pernette R. W. de Sauvage Nolting, MD, PhD; Eric de Groot, MD, PhD; Aeilko H. Zwinderman, PhD; Rudolf J. A. Buirma, MD; Mieke D. Trip, MD, PhD; John J. P. Kastelein, MD, PhD

Arch Intern Med. 2003;163:1837-1841.

Objective  To investigate whether high-dose simvastatin therapy could reduce carotid and femoral artery intima-media thickness (IMT) in patients with familial hypercholesterolemia (FH) to prevent cardiovascular disease.

Background  Imaging of arterial walls with B-mode ultrasonography is increasingly used as a noninvasive surrogate marker of cardiovascular disease. Intervention trials using this modality have shown that by reducing risk factors, progression of atherosclerosis was inhibited.

Methods  After a washout period of 6 weeks, all patients with FH started monotherapy with simvastatin, 80 mg/d, for 2 years. The primary end point was the change (in millimeters) of the mean combined far-wall IMT of predefined carotid and femoral arterial segments at 2 years.

Results  We included a total of 153 patients with FH. Mean ± SD combined baseline IMT was 1.07 ± 0.23 mm. After treatment with simvastatin for 2 years, this IMT decreased by a mean of 0.081 mm (95% confidence interval, -0.109 to -0.053; P<.001), with its largest reduction in the femoral artery (-0.283 mm; P<.001). An actual decrease of combined IMT was seen in 69.8% of all patients.

Conclusions  High-dose simvastatin therapy reduces arterial wall IMT in more than two thirds of the patients, with its largest effect on the femoral artery. Furthermore, patients with FH who were treated with both statin and antihypertensive medication experienced a significantly greater benefit in terms of IMT reduction.


From the Departments of Vascular Medicine (Drs de Sauvage Nolting, de Groot, Trip, and Kastelein) and Clinical Epidemiology and Biostatistics (Dr Zwinderman), Academic Medical Center, Amsterdam, the Netherlands; and the Department of Clinical Research, Merck, Sharp & Dohme, Haarlem, the Netherlands (Dr Buirma). The authors have no relevant financial interest in this article.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Femoral Atherosclerosis In Heterozygous Familial Hypercholesterolemia: Influence Of The Genetic Defect
Junyent et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:580-586.
ABSTRACT | FULL TEXT  

Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease
Essig et al.
Nephrol Dial Transplant 2008;23:239-248.
ABSTRACT | FULL TEXT  

Comparison of intensive and low-dose atorvastatin therapy in the reduction of carotid intimal-medial thickness in patients with coronary heart disease
Yu et al.
Heart 2007;93:933-939.
ABSTRACT | FULL TEXT  

Atherosclerosis imaging in statin intervention trials
Yanai et al.
QJM 2007;100:253-262.
FULL TEXT  

Recent Advances of Intervention to Inhibit Progression of Carotid Intima-Media Thickness in Patients With Type 2 Diabetes Mellitus
Yokoyama et al.
Stroke 2006;37:2420-2427.
ABSTRACT | FULL TEXT  

Pioglitazone Decreases Carotid Intima-Media Thickness Independently of Glycemic Control in Patients With Type 2 Diabetes Mellitus: Results From a Controlled Randomized Study
Langenfeld et al.
Circulation 2005;111:2525-2531.
ABSTRACT | FULL TEXT  

Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging
Yonemura et al.
J Am Coll Cardiol 2005;45:733-742.
ABSTRACT | FULL TEXT  

Statin-Induced Cholesterol Lowering and Plaque Regression After 6 Months of Magnetic Resonance Imaging-Monitored Therapy
Lima et al.
Circulation 2004;110:2336-2341.
ABSTRACT | FULL TEXT  

Atherosclerosis in Patients Infected With HIV Is Influenced by a Mutant Monocyte Chemoattractant Protein-1 Allele
Alonso-Villaverde et al.
Circulation 2004;110:2204-2209.
ABSTRACT | FULL TEXT  

Familial Hypercholesterolemia, Peripheral Arterial Disease, and Stroke: A HuGE Minireview
Hutter et al.
Am J Epidemiol 2004;160:430-435.
ABSTRACT | FULL TEXT  

JournalScan
Malik
Heart 2003;89:1373-1374.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.